Note: Ingredients listed on restricted chemical lists
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
≥0.1-<0.5%
General Information
Version
2.0 (replaces version 1.0
Revision date
2024-11-22
Product name
Protac lyophilized
1.2.1 Relevant identified uses
Diagnostic reagent
Emergency telephone
+41 44 251 51 51
Icons in SDS
Company Information
company name
Pentapharm AG
e-mail address of the competent person responsible for the Safety Data Sheet
pentapharm@pentapharm.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Health hazards
Resp. Sens. 1 H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled Skin Sens. 1 H317 May cause an allergic skin reaction
Hazard pictograms
GHS08
Signal word
Danger (Contd. on page 2) CH/EN (Contd. of page 1)
Hazardous Ingredients
Glycopeptide
Hazard statements
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction.
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves / protective clothing. P285 In case of inadequate ventilation wear respiratory protection. P304+P341 IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER/doctor.
Additional information
5 - 10% of the mixture consists of component(s) of unknown toxicity extracted from snake venom. Classification of the product is derived from the starting material (snake venom extract) and general knowledge of enzyme properties. This product itself has not been tested.
PBT Substances
According to current knowledge, the product contains no PBT substance
vPvB Substances
According to current knowledge, the product contains no vPvB substance Determination of endocrine-disrupting properties Taking into account the current state of scientific knowledge, no data on endocrine disrupting properties of the product are available. *
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 health hazard Resp. Sens. 1 H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin Sens. 1 H317 May cause an allergic skin reaction.
